Publication:
Hypercholesterolemia and Alzheimer's Disease

dc.contributor.authorsAytan, Nurguel; Ozer, Nesrin Kartal
dc.date.accessioned2022-03-12T16:00:17Z
dc.date.accessioned2026-01-10T19:23:53Z
dc.date.available2022-03-12T16:00:17Z
dc.date.issued2008
dc.description.abstractAlzheimer's disease is characterized by the accumulation of amyloid-P peptides in senile plaques and protein aggregates with regional accumulation of hyperphosphorylated tau in neurofibrillary tangles and a dysfunction of the ubiquitin-proteasome system which degrades oxidatively damaged proteins. There is considerable evidence consistent with the importance of oxidative stress in the pathology of Alzheimer's disease and the accumulation of free radicals, leading to excessive lipid peroxidation, oxidative modification of proteins in the brain. Current experimental evidence suggests that an initial source of oxidative stress, such as high cholesterol, may initiate amyloid-beta formation, which by itself is another potent Source of oxidative stress in Alzheimer's disease.
dc.identifier.doidoiWOS:000261306700029
dc.identifier.issn1300-0292
dc.identifier.urihttps://hdl.handle.net/11424/224635
dc.identifier.wosWOS:000261306700029
dc.language.isotur
dc.publisherORTADOGU AD PRES & PUBL CO
dc.relation.ispartofTURKIYE KLINIKLERI TIP BILIMLERI DERGISI
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectHypercholesterolemia, alzheimer disease, oxidative stress
dc.subjectAMYLOID PRECURSOR PROTEIN
dc.subjectOXIDATIVE STRESS
dc.subjectINCIDENT DEMENTIA
dc.subjectLIPID RAFTS
dc.subjectCHOLESTEROL
dc.subjectRISK
dc.subjectNEUROTOXICITY
dc.subjectATHEROSCLEROSIS
dc.subjectINFLAMMATION
dc.subjectMETABOLISM
dc.titleHypercholesterolemia and Alzheimer's Disease
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPageS154
oaire.citation.issue6
oaire.citation.startPageS150
oaire.citation.titleTURKIYE KLINIKLERI TIP BILIMLERI DERGISI
oaire.citation.volume28

Files